CAPRICOR THERAPEUTICS, INC.

CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001133869

Price chart

Open-market purchases and sales by CAPR insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jun 29, 2026Jun 25, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSSaleCommon Stock−24.1K$30.38−$732.16K11.22K−68.2%SEC
Jun 29, 2026Jun 25, 2026Krasney KarenEVP, GENERAL COUNSELSSaleCommon Stock−24.1K$30.38−$732.16K30.55K−44.1%SEC
Jun 24, 2026Jun 22 – Jun 24, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSSaleCommon Stock−900$30.00−$27K11.22K−7.4%SEC
Jun 24, 2026Jun 22 – Jun 24, 2026Krasney KarenEVP, GENERAL COUNSELSSaleCommon Stock−900$30.00−$27K30.55K−2.9%SEC
May 4, 2026May 1, 2026Bergmann AnthonyCHIEF FINANCIAL OFFICERSSaleCommon Stock−25K$31.70−$792.5K8.22K−75.2%SEC10b5-1

The largest institutional positions in CAPR at the end of Q2 2026.

Institutions holding CAPR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.4,145,061$99.81M0.00%+723,246+21.1%Added
TANG CAPITAL MANAGEMENT LLC4,099,900$98.73M4.48%+700,000+20.6%Added
SUVRETTA CAPITAL MANAGEMENT, LLC4,092,784$98.55M2.07%+274,184+7.2%Added
STATE STREET CORP3,397,150$81.8M0.00%+1,215,249+55.7%Added
VANGUARD CAPITAL MANAGEMENT LLC2,297,674$55.33M0.00%+269,942+13.3%Added